The medical technology company Sensodetect has received questions from shareholders regarding the board, communication, and the status of the company's projects, and is now compiling the questions that have come in. "We are currently compiling the questions that have been received, including those concerning the work of the board, timelines, study results, and our international collaborations, and we will issue a clarification regarding this next Tuesday, December 9. Next week we will also publish a Q&A in which we answer the questions that have come in. In connection with this, we will invite to a live Q&A to answer any additional questions," according to a press release.